China Clinical Trial: Shanghai Zhaxin integrated traditional Chinese and Western Medicine Hospital Registers Clinical Trial for Comparing Upfront Transplantation and Pretransplant Cytoreductive Therapy in Intermediate High-risk/High-risk/Very High-risk Myelodysplastic Syndromes (MDS) Patients Based on the IPSS-M Scoring System.

  Processing Request